Schallenberger Mark A. reported XTNT

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001960742-25-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 15, 2025

Published

Nov 18, 2025

Ingested by INSIDER

Nov 5, 04:32 UTC

Last re-read

Nov 5, 04:32 UTC

Extracted facts

Filer

Schallenberger Mark A.

Role

Chief Operating Officer

Transaction

Grant or awardAs filed: “A”

Asset

Xtant Medical Holdings, Inc. — Performance Stock Units (PSUs)

Ticker

XTNT

Shares

584.5K

Price per share

$0

Execution date (reported)

Nov 15, 2025

Owned after transaction

584.5K shares

Days from execution to publication

3

What this establishes

Schallenberger Mark A. filed this Form 4 reporting a grant or award of XTNT on Nov 15, 2025. It became public on Nov 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Operating Officer

Schallenberger Mark A.cik:0001960742

Issuer

Xtant Medical Holdings, Inc.cik:0001453593

Revision history · 0

No field has changed since this record was first ingested.